Markets:

Overview

News

Currencies

International

Treasuries

Charles River Laboratories International, Inc. Common Stock (NY:CRL)

234.80 -5.63 (-2.34%)

Official Closing Price Updated: 4:10 PM EDT, Jul 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

21 22 Next >

These S&P500 stocks are gapping in today's session ↗

July 28, 2026

Via Chartmill

Which S&P500 stocks are gapping on Thursday? ↗

July 23, 2026

Via Chartmill

These S&P500 stocks that are showing activity before the opening bell on Thursday. ↗

July 23, 2026

Via Chartmill

3 Profitable Stocks with Warning Signs

July 23, 2026

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...

Via StockStory

Charles River Laboratories (NYSE:CRL) Beats Q1 Estimates, Reaffirms Guidance ↗

May 07, 2026

Via Chartmill

3 Healthcare Stocks We Approach with Caution

July 22, 2026

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not on...

Via StockStory

What's going on in today's session: S&P500 movers ↗

July 20, 2026

Via Chartmill

Charles River Laboratories Schedules Second-Quarter 2026 Earnings Release and Conference Call

July 15, 2026

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Provides NGS Services to Arovella Therapeutics, Accelerating Progress Toward Alternative Cancer Treatment Approaches

July 13, 2026

From Charles River Laboratories International, Inc.

Via Business Wire

3 Reasons to Avoid CRL and 1 Stock to Buy Instead

July 02, 2026

Charles River Laboratories trades at $225.41 and has moved in lockstep with the market. Its shares have returned 11.4% over the last six months while the S&P...

Via StockStory

Uncover the latest developments among S&P500 stocks in today's session. ↗

June 24, 2026

Via Chartmill

Bio-Rad vs. Charles River Labs: Which Medical Research Stock Is a Better Buy in 2026? ↗

June 22, 2026

Bio-Rad posts robust margins and liquidity, while Charles River leads in global drug discovery services. Explore how their fundamentals stack up for investors.

Via The Motley Fool

Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise

June 18, 2026

From Charles River Laboratories International, Inc.

Via Business Wire

1 S&P 500 Stock on Our Buy List and 2 We Brush Off

June 16, 2026

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch...

Via StockStory

Topics Stocks

Charles River Laboratories to Present at William Blair and Jefferies Conferences

June 01, 2026

From Charles River Laboratories International, Inc.

Via Business Wire

Discover which S&P500 stocks are making waves on Thursday. ↗

May 28, 2026

Via Chartmill

Which S&P500 stocks are moving on Wednesday? ↗

May 27, 2026

Via Chartmill

Drug Development Inputs & Services Stocks Q1 In Review: Charles River Laboratories (NYSE:CRL) Vs Peers

May 17, 2026

Looking back on drug development inputs & services stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Charles River Laborato...

Via StockStory

Topics Economy

The 5 Most Interesting Analyst Questions From Charles River Laboratories’s Q1 Earnings Call

May 14, 2026

Charles River Laboratories’ first quarter results reflected a mix of ongoing business transformation and operational adjustments. Management pointed to the i...

Via StockStory

Topics Earnings

NeoGenomics and Charles River Laboratories Shares Plummet, What You Need To Know

May 13, 2026

What Happened? A number of stocks fell in the afternoon session after the April PPI report showed wholesale inflation accelerating to 6% annually, with servi...

Via StockStory

Topics Economy

Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions

May 13, 2026

From Charles River Laboratories

Via Business Wire

Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow

May 11, 2026

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories International Q1 Earnings Call Highlights ↗

May 09, 2026

Charles River Laboratories International (NYSE:CRL) reported first-quarter 2026 results that management said were in line to slightly ahead of its prior outlook, while reaffirming its full-year organic...

Via MarketBeat

Topics Earnings Economy

These Analysts Increase Their Forecasts On Charles River After Better-Than-Expected Q1 Results ↗

May 08, 2026

Charles River Laboratories (NYSE: CRL) beat Q1 earnings estimates but lowered its FY2026 forecast. Analysts maintain positive outlook with raised price targets.

Via Benzinga

CRL Q1 Deep Dive: Portfolio Restructuring and Cost Initiatives Set Stage for Margin Expansion

May 08, 2026

Lab services company Charles River Laboratories (NYSE:CRL) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 1.2% year on y...

Via StockStory

Topics Artificial Intelligence

Charles River (CRL) Q1 2026 Earnings Transcript ↗

May 07, 2026

Charles River (CRL) Q1 2026 Earnings Transcript

Via The Motley Fool

Charles River Laboratories (NYSE:CRL) Exceeds Q1 CY2026 Expectations

May 07, 2026

Lab services company Charles River Laboratories (NYSE:CRL) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 1.2% year on ...

Via StockStory

Charles River Laboratories Announces First-Quarter 2026 Results

May 07, 2026

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories (CRL) To Report Earnings Tomorrow: Here Is What To Expect

May 05, 2026

Lab services company Charles River Laboratories (NYSE:CRL) will be reporting earnings this Thursday before market hours. Here’s what investors should know. C...

Via StockStory

Charles River Launches Rat In Vitro Fertility Services Demonstrating Embryology Capabilities

April 30, 2026

From Charles River Laboratories

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.